Author

Fonma Essien

Baylor College of Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Abdullah A. OsmaniD· 1 shared Chandrashekar R. AmbatiiD· 1 shared Cristian CoarfaiD· 1 shared Emerald Kan· 1 shared Faye M. JohnsoniD· 1 shared Heath Devin SkinneriD· 1 shared Hussam Dayoub· 1 shared Jeffrey N. MyersiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdullah A. OsmanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting

Pedram Yadollahi, Kelli A. McCord, Li Yang, Hussam Dayoub, Kalil Saab, Fonma Essien, Sean Hyslop, Emerald Kan, Kazi Mokim Ahmed, Parker R. Kirby, Vasanta Putluri, Chandrashekar R. Ambati, Karthik Reddy Kami Reddy, Patricia D. Castro, Heath Devin Skinner, , Vlad Constantin Sandulache

This paper identifies PI3K pathway activation in Nrf2-driven cisplatin-resistant HNSCC and shows that gedatolisib inhibits tumor growth and re-sensitizes cells to cisplatin.

British Journal of Cancer · Oct 6, 2025Peer-reviewedCancer Biology